Siviresta tetrahydrate
|
西維來司他四水合物
|
|
1-acetyl-2,3,5-tribenzoyl-indole-D-ribofuranosyl clonerabine intermediate
|
1-乙?;?2,3,5-三苯甲?;?Β-D-呋喃核糖克羅拉濱中間體
|
|
1,3,5-tribenzoyl-indole-D-ribofuranosyl clonerabine intermediate
|
1,3,5-三苯甲?;?Α-D-呋喃核糖克羅拉濱中間體
|
|
Sodium selenate
|
利塞磷鈉
|
|
Sivires sodium tetrahydrate
|
西維來司鈉四水合物
|
|
Mitiglinide dihydrate
|
米格列奈二水合物
|
|
Faropenem dibasic hemihydrate
|
法羅培南二倍半水合物
|
|
2-deoxy-2-fluoro-tribenzoyl-hydrazide-D-apolofuranose cloramide
|
2-脫氧-2-氟-三苯甲?;?Α-D-阿垃伯呋喃糖克羅垃濱中間體
|
|
Lise phosphate
|
利塞磷酸
|
|
Faropene sodium dihydrate
|
法羅培鈉二倍半水合物
|
|
Doripenem hydrate
|
多尼培南(一水合物)
|
364622-82-2
|
Doripenem
|
多尼培南
|
148016-81-3
|
Mitiglinide calcium
|
米格列奈
|
145525-41-3
|
Olmesartan
|
奧美沙坦酯
|
144689-78-1
|
N-[2-[[[4-(2,2-Dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]-(S)-glycine monosodium salt
|
N-[2-[[[4-(2,2-二甲基-1-氧代丙氧基)苯基]磺酰]氨基]苯甲酰]-(S)-甘氨酸單鈉鹽
|
150374-95-1
|
(5R,6S)-6-[(1R)-1-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 2-propenyl ester
|
6-(1'-叔丁基二甲基硅氧乙基)-3-(2''-四氫呋喃基)-7-氧代-4-硫-1-氮雜雙環(huán)[3.2.0]庚-2-烯-2-羧酸烯丙酯
|
120705-67-1
|
[2(S)-cis]-Octahydro-gamma-oxo-alpha-(phenylmethyl)-2H-isoindole-2-butanoic acid
|
(2S)-2-芐基-3-(順式全氫異吲哚-2-羰基)丙酸
|
145375-43-5
|
(5-acetyloxy-3,4-dibenzoyloxy-oxolan-2-yl)methyl benzoate
|
1-乙酰氧基-2,3,5-三苯甲酰氧基-1-ALPHA-D-呋喃核糖
|
70832-64-3
|
5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole
|
N-(三苯基甲基)-5-(4'-甲基聯(lián)苯-2-基)四氮唑
|
124750-53-4
|
Olmesartan ethyl este
|
奧美沙坦乙酯
|
|
Olmesartan medoxomil impurity III
|
奧美沙坦酯雜質(zhì)III
|
|
Olmesartan medoxomil impurity V
|
奧美沙坦酯雜質(zhì)V
|
157356-74-6
|
Trityl olmesartan impurity I
|
三苯甲基奧美沙坦酯雜質(zhì)I
|
|
Trityl olmesartan impurity II
|
三苯甲基奧美沙坦酯雜質(zhì)II
|
|
Olmesartan medoxomil impurity IV
|
奧美沙坦酯雜質(zhì)IV
|
1040250-19-8
|
Quinazoline, 2-(chloromethyl)-4-methyl-
|
2-氯甲基-4-甲基喹唑啉
|
109113-72-6
|
Olmesartan intermediate impurity IV
|
咪唑單乙酯雜質(zhì)IV
|
1092980-84-1
|
[1,1'-Biphenyl]-4-carboxylic acid,hexahydro-2-oxo-4-(3-oxodecyl)-2H-cyclopenta[b]furan-5-yl ester,[3aR-(3a,4,5,6a)]-
|
[1,1'-聯(lián)苯]-4-羧酸,六氫-2-氧代-4-(3-氧代癸烯基)-2H-環(huán)戊并[b]呋喃-5-基酯,[3aR-(3a,4,5,6a)]-
|
120373-45-7
|
Olmesartan intermediate impurity II
|
咪唑單乙酯雜質(zhì)II
|
144690-07-3
|
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetraz ol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, ethyl ester
|
三苯甲基奧美沙坦乙酯
|
144690-33-5
|
(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester
|
(5R-CIS)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氫呋喃-3-基甲基酯(泊沙康唑主環(huán))
|
149809-43-8
|
Olmesartan intermediate impurity VI
|
咪唑單乙酯雜質(zhì)VI
|
157356-73-5
|
(S)-N-[[3-[3-Fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine
|
(S)-5-(氨基甲基)-3-(3-氟-4-嗎啉基苯基)-2-唑烷酮
|
168828-90-8
|
Olmesartan intermediate impurity I
|
咪唑單乙酯雜質(zhì)V
|
172875-53-5
|
3-Carbamoymethyl-5-methylhexanoic acid
|
3-氨基甲酰甲基-5-甲基己酸
|
181289-15-6
|
(R)-(-)-3-(Carbamoymethyl)-5-methylhexanoic acid
|
(R)-(-)-3-氨基甲酰甲基-5-甲基己酸
|
181289-33-8
|
2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one
|
2-[(1S,2S)-1-乙基-2-芐氧基丙基]-2,4-二氫-4-[4-[4-(4-羥基苯基)-1-哌嗪基]苯基]-3H-1,2,4-三氮唑-3-酮(泊沙康唑側(cè)鏈)
|
184177-83-1
|
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
|
1-乙基-(3-二甲氨基丙基)碳酰二亞胺鹽酸鹽
|
25952-53-8
|
(R)-3-(Boc-Amino)piperidine
|
(R)-3-Boc-氨基哌啶
|
309956-78-3
|
(-)-Corey Lactone Benzoate
|
(3aR,4S,5R,6aS)-5-(苯甲酰氧基)六氫-4-(羥基甲基)-2H-環(huán)戊并[b]呋喃-2-酮
|
39746-00-4
|
[1,1'-Biphenyl]-4-carboxylic acid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
[1,1'-聯(lián)苯]-4-羧酸,(3aR,4R,5R,6aS)-六氫-4-[(1E,3S)-3-羥基-1-辛烯-1-基]-2-氧代-2H-環(huán)戊并[b]呋喃-5-基酯
|
51014-26-7
|
(R)-N-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide
|
(R)-2-羥基-N-(4-硝基苯乙基)-2-苯基乙酰胺
|
521284-19-5
|
(alphaR)-alpha-[[[2-(4-Nitrophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride
|
(R)-2-(4-硝基苯乙基氨基)-1-苯基乙醇鹽酸鹽
|
521284-21-9
|
8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione
|
8-溴-7-(2-丁炔基)-3,7-二氫-3-甲基-1H-嘌呤-2,6-二酮
|
666816-98-4
|
2(1H)-Pentalenone, 5-(benzoyloxy)hexahydro-4-(hydroxymethyl)-, [3aS-(3a,4,5,6a)]-
|
2(1H)-并環(huán)戊二烯酮,5-(苯甲酰氧基)六氫-4-(羥甲基)-,[3aS-(3a,4,5,6a)]-
|
74842-93-6
|
Trityl olmesartan acid
|
三苯甲基奧美沙坦酸
|
761404-85-7
|
(3as,4R,5S,6ar)-(+)-hexahydro-5-hydroxy-4-hoch2-2
|
(3aS,4R,5S,6aR)-六氫-5-羥基-4-(羥甲基)-2H-環(huán)戊并[b]呋喃-2-酮
|
76704-05-7
|
4-(chloromethyl)-5-methyl-1,3-dioxol-2-one
|
4-氯甲基-5-甲基-1,3-二氧雜環(huán)戊烯-2-酮
|
80841-78-7
|
1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
|
8-溴-7-(2-丁炔-1-基)-3,7-二氫-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮
|
853029-57-9
|
Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-
|
2-[(6-氯-3,4-二氫-3-甲基-2,4-二氧代-1(2H)-嘧啶基)甲基]苯甲腈
|
865758-96-9
|
4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester
|
奧美沙坦酯雜質(zhì)I
|
879562-26-2
|
Olmesartan medoxomil impurity II
|
奧美沙坦酯雜質(zhì)II
|
896419-17-3
|
1,3-Dioxol-2-one, 4-(hydroxymethyl)-5-methyl-
|
4-羥甲基-5-甲基-1,3-二氧雜環(huán)戊烯-2-酮
|
91526-18-0
|
3-Methyl-8-bromoxanthine
|
8-溴-3-甲基-3,7-二氫-嘌呤-2,6-二酮
|
93703-24-3
|
(3aR,6aS)-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-2-one
|
(1R,5S)-2-氧雜二環(huán)[3.3.0]辛-6-烯-3-酮
|
26054-46-6
|
Trityl olmesartan impurity III
|
三苯甲基奧美沙坦酯雜質(zhì)III
|
|
6-[1-[(tert-Butyldimethylsilyl)oxy]ethyl]-7-oxo-3-(tetrahydro-3-furanyl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 2-propenyl ester
|
6-[1-[(叔丁基二甲基硅)氧]乙基]-7-氧代-3-(四氫-3-呋喃基)-4-硫雜-1-氮雜雙環(huán)[3.2.0]庚-2-烯-2-羧酸烯丙酯
|
120705-71-7
|